|
Bextra®
recall Pennsylvania.
If
you are currently on Bextra check with your doctor, especially
if you have a history of heart problems.
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the
market "because the overall risk versus benefit profile for
the drug is unfavorable."
Bextra® is a non-steroidal anti-inflammatory drug
(NSAIDs), known as a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer
and Vioxx® is manufactured by Merck. Doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due studies showing an increased risk for heart attack
and stroke.
bextra
site map
-
For
a free case evaluation from a Pennsylvania attorney, click here:
http://www.lawforum.net/areas/bextra/pennsylvania/
-
Munley,
Munley & Cartwright, P.C. is a Pennsylvania law office which
has breaking news and information about this lawsuit http://www.munley.com/drugs/bextra.html
-
Click
here to read the FDA questions and answers about strengthened warnings on Bextra®
boxes http://www.fda.gov/cder/drug/infopage/bextra/bextraQA.htm
-
To
report any unexpected adverse or serious events associated
with the use of Bextra® contact the FDA MedWatch program
at: 1-800-FDA-1088 or on the Internet at http://www.fda.gov/medwatch/index.html
Autism
Education Materials!
|
